Inflammation and Sudden Death Signals

> Research explainer: This briefing examines verified primary research published 78 days before the briefing date. It is not a same-day research update and does not provide medical advice.

Evidence

This research explainer covers a prospective substudy of VICTORIA, a prospective, double-blind, multinational, randomized-controlled trial. The substudy included 4,391 participants with chronic, worsening heart failure; reduced left ventricular ejection fraction below 45%; elevated N-terminal pro–B-type natriuretic peptide; recent heart-failure decompensation; and valid baseline QT-interval and biomarker data. pmid:42308652

Investigators collected baseline demographic, historical, electrolyte, ECG, and biomarker data. Independent blinded reviewers at a centralized core laboratory interpreted baseline ECGs. QT was preferentially measured in lead II, with V5 or V6 used when lead II was unsuitable, and the tangential line method was used where appropriate. Cox proportional-hazards and linear-regression models assessed associations; the reported significance threshold was a two-sided P value below 0.05, without correction for multiple testing. pmid:42308652

The prespecified biomarker focus included interleukin-6, growth differentiation factor-15, and high-sensitivity C-reactive protein (hsCRP). JTc was defined as QTc minus QRS duration. The study examined their relationships with sudden cardiac death and whether inflammatory biomarkers added prognostic information beyond ECG parameters. pmid:42308652

JTc interval, but not QTc interval, was associated with sudden cardiac death: HR 0.97 per 10 ms, 95% CI 0.94-1.00, P = 0.043. All three biomarkers were associated with increased sudden-cardiac-death risk in univariable analysis, but only hsCRP remained significant in multivariable models. For hsCRP, the reported multivariable association was HR 1.20 per doubling, P < 0.001. pmid:42308652

Analysis — Prognostic signals

The findings distinguish association from mechanism. A JTc association and an hsCRP association with sudden cardiac death were reported within the same trial-derived cohort, while QTc was not associated with the outcome. This pattern supports the authors’ framing that inflammatory and repolarization-related measures may capture different prognostic information, but it does not show that inflammation causes sudden cardiac death or that changing hsCRP would alter risk. pmid:42308652

The comparator within the ECG analysis matters: JTc, not QTc, was associated with sudden cardiac death. Because JTc incorporates QRS duration by subtracting it from QTc, the result should be read as evidence about the measured repolarization metric in this population, rather than as a general conclusion that one ECG measure is universally superior. The reported confidence interval for JTc was close to 1.00, and statistical significance alone does not establish clinical significance. pmid:42308652

The biomarker result is also conditional on the modeling approach. All three biomarkers showed univariable associations, whereas only hsCRP remained significant in multivariable models. That attenuation is relevant because it indicates that reported associations can differ after accounting for covariates; it does not identify a biomarker-driven pathway. Growth differentiation factor-15 was independently associated with QTc and JTc intervals, further indicating that the ECG and biomarker observations were related but not interchangeable. pmid:42308652

Taken together, the study provides an exploratory prognostic signal in people with worsening heart failure with reduced ejection fraction and recent decompensation. It does not provide a patient-specific conclusion, a treatment recommendation, or evidence that these measures should be used independently to make clinical decisions. pmid:42308652

Limitations

The authors described the analysis as exploratory and did not correct for multiple testing. Therefore, the reported P values should be interpreted with that design feature in mind. pmid:42308652

Although the models adjusted for baseline heart-failure risk, amiodarone, and electrolytes, other confounders could remain, including information on shocks received by patients with ICD therapy. Residual confounding limits causal interpretation of biomarker and ECG associations. pmid:42308652

QT measurement used a single ECG, which may have missed dynamic changes. The supplied evidence describes this trial-derived substudy population and its methods; it does not establish how findings apply outside that setting. pmid:42308652